Ferri V, Vicente E, Quijano Y, Duran H, Diaz E, Fabra I, Malave L, Ruiz P, Isernia R, Caruso R. Giant fibrovascular polyps of the esophagus. Trans oral versus surgical approach. Case report and systematic literature review.
Int J Surg Case Rep 2022;
97:107412. [PMID:
35917607 PMCID:
PMC9403098 DOI:
10.1016/j.ijscr.2022.107412]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Revised: 07/08/2022] [Accepted: 07/09/2022] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION
Giant fibrovascular esophageal polyp is a rare benign intraluminal tumour. The aim of this study is to perform a review of the most recent literature in order to describe and analyse the current range of possible diagnostics and treatment strategies.
CASE REPORT
We present two cases of giant fibrovascular esophageal polyp treated with a combined minimally invasive transluminal approach at Sanchinarro University Hospital. Further, we perform a literature review.
CONCLUSION
We present two cases of grant fibrovascular polyp submitted to minimally invasive transluminal approach. Furthermore, 54 original articles reporting 59 cases have been analysed. In the surgical group, an esophagotomy and polyp resection were performed in 31 (91 %) patients and a total esophagectomy in two patients (5,8 %). Severe morbidity occurred in two patients (5,8 %.) The median hospital stay was 9.25 days. A total of two (5,8 %) cases of recurrence have been registered. In the minimally invasive transluminal approach group, 27 patients had a polyp resection performed completely by endoscopy/transoral. There were no complications but there was one case of recurrence.
CONCLUSION
The transluminal approach is safe and should be considered also in the treatment of large esophageal polyps.
Collapse